It is extremely encouraging that in less than 6 years CART-19 went from new clinical trial status to Food & Drug Administration (FDA) approval for treatment. The very first FDA approved immunotherapy treatment was for an adult prostate cancer in 2010. In 2011, six-year old Emily Whitehead received the first pediatric trial of a novel…